Luis Jr Izquierdo
Luis Jr Izquierdo has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Maria A. Henriquez
Research Department, Oftalmosalud Eye Institute, Lima, Peru
4 shared publicationsClaudia Pomatanta
Research Department, Oftalmosalud Eye Institute, Lima, Peru
2 shared publications- Maria Alejandra Md Henriquez
Research Department, Oftalmosalud Institute of Eyes, Av. Javier Prado Este 1142, San Isidro, Lima 27, Perú
2 shared publications Rolando Rojas
Research Department, Oftalmosalud Eye Institute, Lima, Peru
2 shared publicationsDaniel Sossa
From the Research Department, Oftalmosalud Institute of Eyes, Lima, Perú
1 shared publicationGuillermo Raul Vera-Duarte
Departamento de Investigación, Instituto de Ojos, OftalmoSalud, Av. Javier Prado Este 1142, San Isidro, Lima 27, Peru
1 shared publication
Latest Publications
- Open Access
- 31 October 2026
- Published by Springer Nature in BMC Ophthalmology
- Vol. 26 (1)
Short-term comparative outcomes of toric ICL implantation versus femtosecond LASIK for myopic astigmatism
- 31 October 2026
- Published by Springer Nature in BMC Ophthalmology
- Vol. 26 (1)
Open AccessShort-term comparative outcomes of toric ICL implantation versus femtosecond LASIK for myopic astigmatism
- 19 June 2026
- Published by Springer Nature in International Ophthalmology
- Vol. 46 (1)
Topical 0.02% tacrolimus as adjunctive immunoprophylaxis in high-risk penetrating keratoplasty: a four-year retrospective study
To describe the incidence and clinical profile of graft rejection in high-risk penetrating keratoplasty (PK) recipients treated with a compounded topical formulation of 0.02% tacrolimus combined with 1% prednisolone. This retrospective observational study included 41 eyes from 41 high-risk PK patients operated between 2019 and 2023 at the Oftalmosalud Eye Institute (Lima, Peru), with a minimum follow-up of 12 months. All patients received adjunctive immunoprophylaxis with topical 0.02% tacrolimus and 1% prednisolone, initiated on the first postoperative day and maintained throughout follow-up. High-risk PK refers to corneal transplantation in eyes with predisposing factors for immune-mediated graft rejection. Graft rejection episodes were classified as reversible or irreversible based on clinical course and treatment response. Graft rejection occurred in 15 of 41 eyes (36.6%), with 60% of these episodes being reversible and 40% irreversible. The remaining 26 eyes (63.4%) maintained clear grafts without signs of rejection. The most frequent high-risk clinical features were corneal neovascularization in 21 eyes (51.2%), ocular surface disease in 9 eyes (21.9%), and persistent inflammation in 7 eyes (17.0%). No serious adverse events related to topical tacrolimus were observed. Topical 0.02% tacrolimus in combination with prednisolone may represent a safe adjunctive strategy in high-risk PK. These findings support the incorporation of topical tacrolimus into immunosuppressive regimens for high-risk corneal transplantation. Prospective controlled trials are warranted to confirm its long-term efficacy and safety.
- 19 June 2026
- Published by Springer Nature in International Ophthalmology
- Vol. 46 (1)
Topical 0.02% tacrolimus as adjunctive immunoprophylaxis in high-risk penetrating keratoplasty: a four-year retrospective study
To describe the incidence and clinical profile of graft rejection in high-risk penetrating keratoplasty (PK) recipients treated with a compounded topical formulation of 0.02% tacrolimus combined with 1% prednisolone. This retrospective observational study included 41 eyes from 41 high-risk PK patients operated between 2019 and 2023 at the Oftalmosalud Eye Institute (Lima, Peru), with a minimum follow-up of 12 months. All patients received adjunctive immunoprophylaxis with topical 0.02% tacrolimus and 1% prednisolone, initiated on the first postoperative day and maintained throughout follow-up. High-risk PK refers to corneal transplantation in eyes with predisposing factors for immune-mediated graft rejection. Graft rejection episodes were classified as reversible or irreversible based on clinical course and treatment response. Graft rejection occurred in 15 of 41 eyes (36.6%), with 60% of these episodes being reversible and 40% irreversible. The remaining 26 eyes (63.4%) maintained clear grafts without signs of rejection. The most frequent high-risk clinical features were corneal neovascularization in 21 eyes (51.2%), ocular surface disease in 9 eyes (21.9%), and persistent inflammation in 7 eyes (17.0%). No serious adverse events related to topical tacrolimus were observed. Topical 0.02% tacrolimus in combination with prednisolone may represent a safe adjunctive strategy in high-risk PK. These findings support the incorporation of topical tacrolimus into immunosuppressive regimens for high-risk corneal transplantation. Prospective controlled trials are warranted to confirm its long-term efficacy and safety.
- Open Access
- 20 January 2023
- Published by Wolters Kluwer Health in Cornea
- Vol. 42 (11) , 1391-1394
Interface Fluid Syndrome After Descemet Membrane Endothelial Keratoplasty in Patients With History of LASIK
Purpose: The aim of this study was to evaluate the visual, pachymetric, tomographic, and biomicroscopic findings in a series of cases with laser in situ keratomileusis (LASIK) flap interface fluid syndrome (IFS) after Descemet membrane endothelial keratoplasty (DMEK). Methods: Six cases were included in this study; all patients had a history of LASIK and underwent DMEK for the treatment of bullous keratopathy. After uneventful surgery, all patients presented with corneal edema and IFS under the LASIK flap, which was demonstrated with anterior segment optical coherence tomography (AS-OCT). Visual acuity, clinical findings, pachymetry, endothelial cell count, and AS-OCT were documented during the management of these cases. Results: IFS appears 2.33 days (±1.03) after DMEK. One case improved with conservative treatment. In 5 cases, the LASIK flap was lifted, the fluid was drained, and the flap was replaced. The mean best-corrected visual acuity after fluid drainage was 0.44 logMAR (range 0.18–1.0) and mean central corneal thickness was 538 μm ± 160. Total resolution of the IFS was achieved at 14.5 days (range 4–30) after DMEK. AS-OCT showed resolution of the flap interface in 5 of 6 cases, while 1 patient required second DMEK due to reaccumulation of the interface fluid. Conclusions: IFS can occur after DMEK in patients with previous LASIK. AS-OCT is a valuable tool for monitoring these cases preoperatively and postoperatively. Early surgical management is often needed to achieve resolution.
- 20 January 2023
- Published by Wolters Kluwer Health in Cornea
- Vol. 42 (11) , 1391-1394
Open AccessInterface Fluid Syndrome After Descemet Membrane Endothelial Keratoplasty in Patients With History of LASIK
Purpose: The aim of this study was to evaluate the visual, pachymetric, tomographic, and biomicroscopic findings in a series of cases with laser in situ keratomileusis (LASIK) flap interface fluid syndrome (IFS) after Descemet membrane endothelial keratoplasty (DMEK). Methods: Six cases were included in this study; all patients had a history of LASIK and underwent DMEK for the treatment of bullous keratopathy. After uneventful surgery, all patients presented with corneal edema and IFS under the LASIK flap, which was demonstrated with anterior segment optical coherence tomography (AS-OCT). Visual acuity, clinical findings, pachymetry, endothelial cell count, and AS-OCT were documented during the management of these cases. Results: IFS appears 2.33 days (±1.03) after DMEK. One case improved with conservative treatment. In 5 cases, the LASIK flap was lifted, the fluid was drained, and the flap was replaced. The mean best-corrected visual acuity after fluid drainage was 0.44 logMAR (range 0.18–1.0) and mean central corneal thickness was 538 μm ± 160. Total resolution of the IFS was achieved at 14.5 days (range 4–30) after DMEK. AS-OCT showed resolution of the flap interface in 5 of 6 cases, while 1 patient required second DMEK due to reaccumulation of the interface fluid. Conclusions: IFS can occur after DMEK in patients with previous LASIK. AS-OCT is a valuable tool for monitoring these cases preoperatively and postoperatively. Early surgical management is often needed to achieve resolution.
- Open Access
- 9 September 2020
- Published by IntechOpen
How to Improve Visual Acuity in Keratoconic Cornea?
Keratoconus is one of the most important corneal diseases that causes preventable blindness, so we decided to review the main techniques for improving visual acuity in patients with progressive and nonprogressive keratoconus, in order to expand knowledge in relation to the range of therapeutic possibilities that exist today and the benefits and risks of each of these alternatives.
- 9 September 2020
- Published by IntechOpen
Open AccessHow to Improve Visual Acuity in Keratoconic Cornea?
Keratoconus is one of the most important corneal diseases that causes preventable blindness, so we decided to review the main techniques for improving visual acuity in patients with progressive and nonprogressive keratoconus, in order to expand knowledge in relation to the range of therapeutic possibilities that exist today and the benefits and risks of each of these alternatives.
- 26 August 2020
- Published by Wolters Kluwer Health in Cornea
- Vol. 39 (12) , 1578-1580
Automated Keratopigmentation in Boston Type 1 Keratoprosthesis: An Aesthetic Alternative
Two male patients, aged 64 and 55 years old, presented at the cornea department for a Boston type 1 keratoprosthesis (Kpro I) implantation after multiple corneal graft failures. After surgery, they achieved a best corrected visual acuity of 20/200 and 20/150, respectively. However, they manifested photophobia and aesthetic complaints. Both patients underwent keratopigmentation to improve the aesthetic outcome using vegetable pigments, after mechanical corneal deepithelization, with no intraoperative or postoperative incidents or adverse events. After 1-year follow-up, the patients presented the same best corrected visual acuity with improvement of the aesthetic outcome.
- 26 August 2020
- Published by Wolters Kluwer Health in Cornea
- Vol. 39 (12) , 1578-1580
Automated Keratopigmentation in Boston Type 1 Keratoprosthesis: An Aesthetic Alternative
Two male patients, aged 64 and 55 years old, presented at the cornea department for a Boston type 1 keratoprosthesis (Kpro I) implantation after multiple corneal graft failures. After surgery, they achieved a best corrected visual acuity of 20/200 and 20/150, respectively. However, they manifested photophobia and aesthetic complaints. Both patients underwent keratopigmentation to improve the aesthetic outcome using vegetable pigments, after mechanical corneal deepithelization, with no intraoperative or postoperative incidents or adverse events. After 1-year follow-up, the patients presented the same best corrected visual acuity with improvement of the aesthetic outcome.
- 6 May 2020
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 46 (9) , 1217-1221
Corneal lenticule extraction assisted by a low-energy femtosecond laser
A lenticule of intrastromal corneal tissue was cut together with 2 small incisions of 3.0 mm using a low-energy femtosecond laser system, FEMTO LDV Z8; 1 incision led to the posterior plane and 1 to the anterior, allowing dissection of the lenticule. When needed, recentering of the treatment area was possible without repeating the docking stage. Five eyes were operated, and a complete dissection and removal of the lenticule was achieved in all cases without any intraoperative complications. In addition, at postoperative day 1, all patients had a clear cornea. In conclusion, guided lenticule extraction using a low-energy femtosecond laser was a promising and easy procedure.
- 6 May 2020
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 46 (9) , 1217-1221
Corneal lenticule extraction assisted by a low-energy femtosecond laser
A lenticule of intrastromal corneal tissue was cut together with 2 small incisions of 3.0 mm using a low-energy femtosecond laser system, FEMTO LDV Z8; 1 incision led to the posterior plane and 1 to the anterior, allowing dissection of the lenticule. When needed, recentering of the treatment area was possible without repeating the docking stage. Five eyes were operated, and a complete dissection and removal of the lenticule was achieved in all cases without any intraoperative complications. In addition, at postoperative day 1, all patients had a clear cornea. In conclusion, guided lenticule extraction using a low-energy femtosecond laser was a promising and easy procedure.